Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Jones

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Chemosphere|July 5, 2025
Letter to the editorMark E Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Towards better surveillance of bacterial antibiotic resistanceMark E. Jones
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniaeJames A Karlowsky, Mark E Jones
Biotechnology and Bioengineering|April 5, 2014
Solar flux, water, and land impose limits on biologyMark E Jones, William F Banholzer
Medicine and Science in Sports and Exercise|March 16, 2026
Effectiveness of Structured Breathwork Interventions on Heart Rate Variability and Heart Rate Recovery Following Maximal Exertion in Tactical AthletesMark E Jones, Geneveive Smith, Anthony Acevedo, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 5, 2019
Evaluation of reagents used to coat the hollow-fiber bioreactor membrane of the Quantum® Cell Expansion System for the culture of human mesenchymal stem cellsNathan D Frank, Mark E Jones, Boah Vang, et al.
Postgraduate Medicine|October 24, 2008
Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspectiveDaniel F Sahm, Nina P Brown, Clyde Thornsberry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoinJames A Karlowsky, Clyde Thornsberry, Mark E Jones, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against <i>Streptococcus pneumoniae</i> Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select SerotypesHelio S Sader, Mariana Castanheira, Mark E Jones, et al.
Emerging Infectious Diseases|January 17, 2004
Factors influencing fluoroquinolone resistanceDaniel F Sahm, Clyde Thornsberry, Mark E Jones, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Chemosphere|July 5, 2025
Letter to the editorMark E Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Towards better surveillance of bacterial antibiotic resistanceMark E. Jones
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniaeJames A Karlowsky, Mark E Jones
Biotechnology and Bioengineering|April 5, 2014
Solar flux, water, and land impose limits on biologyMark E Jones, William F Banholzer
Medicine and Science in Sports and Exercise|March 16, 2026
Effectiveness of Structured Breathwork Interventions on Heart Rate Variability and Heart Rate Recovery Following Maximal Exertion in Tactical AthletesMark E Jones, Geneveive Smith, Anthony Acevedo, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 5, 2019
Evaluation of reagents used to coat the hollow-fiber bioreactor membrane of the Quantum® Cell Expansion System for the culture of human mesenchymal stem cellsNathan D Frank, Mark E Jones, Boah Vang, et al.
Postgraduate Medicine|October 24, 2008
Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspectiveDaniel F Sahm, Nina P Brown, Clyde Thornsberry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoinJames A Karlowsky, Clyde Thornsberry, Mark E Jones, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against <i>Streptococcus pneumoniae</i> Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select SerotypesHelio S Sader, Mariana Castanheira, Mark E Jones, et al.
Emerging Infectious Diseases|January 17, 2004
Factors influencing fluoroquinolone resistanceDaniel F Sahm, Clyde Thornsberry, Mark E Jones, et al.
Pageof 7